Celera Q3 Revenues Surge: Company Ramping up R&D for Proteomics Effort | GenomeWeb

NEW YORK, April 26 - Celera said Thursday its third-quarter fiscal 2001 revenues rose to $23.4 million, from $11.1 million in the year-ago period, as the company continued to add subscribers to its database and to initiate new collaborations.

This quarter’s doubling in revenues over the previous year’s quarter continued a trend that began in Celera’s first fiscal quarter. With this continued upsurge, Celera said it was still on track to double its revenues by the end of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.